Our vision at Roche Diabetes Care is to help people with diabetes everywhere in the world think less about their daily diabetes routine so they can experience true relief, day and night.
Roche Diabetes Care has been pioneering innovative diabetes technologies and services for more than 40 years. More than 5,500 employees in over 100 markets worldwide work every day to support people with diabetes and those at risk to achieve more time in their target ranges and experience true relief from their daily therapy routines.
iPDM is a structured and value-based therapy approach enabled by digital solutions designed to improve therapy outcomes in diabetes.
We develop solutions to facilitate personalised care for all people with diabetes wherever they may be in their diabetes journey, whilst ensuring they remain the focus of our approach.
Under the brands RocheDiabetes, Accu-Chek and mySugr®, comprising glucose monitoring, insulin delivery and digital solutions, we unite with our partners to create patient-centric value and facilitate iPDM.
An open ecosystem supports our iPDM approach by allowing broad connectivity between own and partner devices.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.